Monitor the final prospectus supplement for the offering size and pricing. The company's going concern risk and need for capital suggest further dilution may be necessary, and the recall of the CGuard Prime 135 cm delivery system adds operational uncertainty.
NSPR drugs
NSPR drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 13 $0.6441entry
- T+1 · yesterday −6.85%α −4.94% · $0.6000
- T+2 · todayOpen
- T+5 · in 3d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
InspireMD announced a proposed public offering of common stock, pre-funded warrants, and common warrants, with an over-allotment option for underwriters. The offering is intended to raise capital for research, sales, marketing, and working capital, but the size and terms are undisclosed. The company has a $36M market cap, a history of losses, and a going concern risk, making this a dilutive event that pressures existing shareholders.
Key Facts
- InspireMD commenced a proposed public offering of common stock, pre-funded warrants, and common warrants.
- Underwriters have a 30-day option to purchase additional securities representing 15% of the offering for over-allotments.
- Lake Street Capital Markets is the sole book runner.
- Proceeds will be used for R&D, sales and marketing, working capital, and general corporate purposes.
- The offering is subject to market conditions; size and terms are not disclosed.
- The company has a market cap of $36M and a history of losses, with substantial doubt about its ability to continue as a going concern.
Financial Impact
Undisclosed amount; the offering will dilute existing shareholders, with potential for up to 15% additional over-allotment shares.
Risk Factors
- Dilution to existing shareholders from the offering and over-allotment option.
- Company has substantial doubt about its ability to continue as a going concern.
- Voluntary recall of the CGuard Prime 135 cm delivery system may impact sales and incur costs.
- Offering may not be completed on favorable terms or at all.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3402241 |
Track record
29 reports on NSPR
5 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +54.19% at T+60 after the Apr 3, 2026 report. 9 of 13 went positive at some point.
Filters
- Nov 17, 2026today Insider Cluster Mixed 5/10 Entry $0.6500 Now $0.6500 −0.00% settles Feb 17
- Nov 16, 20261d ago 8-K Bearish 6/10 Entry $0.6441 Now $0.6500 −0.92% settles Feb 12
- Nov 16, 20261d ago 424B5 Bearish 6/10 Entry $0.6441 Now $0.6500 −0.92% settles Feb 12
- Nov 13, 20264d ago Press Release Bearish 6/10 Entry $0.6441 Now $0.6500 −0.92% settles Feb 11
- Nov 12, 20264d ago 424B5 Bearish 6/10 Entry $0.6441 Now $0.6500 −0.92% settles Feb 11
- Nov 12, 20264d ago 8-K Bullish 7/10 No price data
- Nov 12, 20264d ago 8-K Bullish 6/10 Entry $0.6441 Now $0.6500 +0.92% settles Feb 11
- Nov 12, 20265d ago Press Release Bearish 5/10 Viewing Entry $0.6441 Now $0.6500 −0.92% settles Feb 11
- Nov 12, 20265d ago Press Release Bullish 7/10 Entry $0.6441 Now $0.6500 +0.92% settles Feb 11
- Nov 12, 20265d ago Press Release Bullish 8/10 Entry $0.6441 Now $0.6500 +0.92% settles Feb 11
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers